The MEK/ERK pathway is the primary conduit for Borrelia burgdorferi-induced inflammation and P53-mediated apoptosis in oligodendrocytes

Apoptosis

Volumn 19, Issue 1, 2014, Pages 76-89

  Parthasarathy, Geetha ^a   Philipp, Mario T ^a  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

Author keywords

Apoptosis; Borrelia burgdorferi; Inflammation; MAPK; Oligodendrocytes

Indexed keywords

CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P53;

APOPTOSIS; ARTICLE; BORRELIA BURGDORFERI; CELL ASSAY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLIA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOTHESIS; INFLAMMATION; INHIBITION KINETICS; MICROGLIA; NERVE CELL; NICK END LABELING; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

BORRELIA BURGDORFERI; CELL LINE; HUMANS; INFLAMMATION MEDIATORS; LYME NEUROBORRELIOSIS; MAP KINASE SIGNALING SYSTEM; OLIGODENDROGLIA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84892777247     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-013-0913-8     Document Type: Article

References (55)

1. Jaenson TG (1991) The epidemiology of lyme borreliosis. Parasitol Today 7(2):39-45
2. Bacon RM, Kugeler KJ, Mead PS (2008) Surveillance for Lyme disease-United States, 1992-2006. MMWR Surveill Summ 57(10):1-9
3. Steere AC (2001) Lyme disease. N Engl J Med 345(2):115-125. doi:10.1056/NEJM200107123450207
4. Halperin JJ (1997) Neuroborreliosis: central nervous system involvement. Semin Neurol 17(1):19-24. doi:10.1055/s-2008-1040908
5. Vallat JM, Hugon J, Lubeau M, Leboutet MJ, Dumas M, Desproges-Gotteron R (1987) Tick-bite meningoradiculoneuritis: clinical, electrophysiologic, and histologic findings in 10 cases. Neurology 37(5):749-753
6. Benach JL, Garcia-Monco JC (1992) Aspects of the pathogenesis of neuroborreliosis. In: Schutzer S (ed) Lyme disease: molecular and immunological approaches. Cold Spring Harbor Laboratory Press, Plainview, New York, pp 1-10
7. Philipp MT, Aydintug MK, Bohm RP Jr, Cogswell FB, Dennis VA, Lanners HN, Lowrie RC Jr, Roberts ED, Conway MD, Karacorlu M, Peyman GA, Gubler DJ, Johnson BJ, Piesman J, Gu Y (1993) Early and early disseminated phases of Lyme disease in the rhesus monkey: a model for infection in humans. Infect Immun 61(7):3047-3059
8. Roberts ED, Bohm RP Jr, Cogswell FB, Lanners HN, Lowrie RC Jr, Povinelli L, Piesman J, Philipp MT (1995) Chronic Lyme disease in the rhesus monkey. Lab Invest 72(2):146-160
9. England JD, Bohm RP Jr, Roberts ED, Philipp MT (1997) Mononeuropathy multiplex in rhesus monkeys with chronic Lyme disease. Ann Neurol 41(3):375-384. doi:10.1002/ana. 410410313
10. Cadavid D, Bai Y, Hodzic E, Narayan K, Barthold SW, Pachner AR (2004) Cardiac involvement in non-human primates infected with the Lyme disease spirochete Borrelia burgdorferi. Lab Invest 84(11):1439-1450. doi:10.1038/labinvest.3700177
11. Beck G, Habicht GS, Benach JL, Coleman JL, Lysik RM, O'Brien RF (1986) A role for interleukin-1 in the pathogenesis of Lyme disease. Zentralbl Bakteriol Mikrobiol Hyg A 263(1-2):133-136
12. Straubinger RK, Straubinger AF, Harter L, Jacobson RH, Chang YF, Summers BA, Erb HN, Appel MJ (1997) Borrelia burgdorferi migrates into joint capsules and causes an up-regulation of interleukin-8 in synovial membranes of dogs experimentally infected with ticks. Infect Immun 65(4):1273-1285
13. Burns MJ, Sellati TJ, Teng EI, Furie MB (1997) Production of interleukin-8 (IL-8) by cultured endothelial cells in response to Borrelia burgdorferi occurs independently of secreted [corrected] IL-1 and tumor necrosis factor alpha and is required for subsequent transendothelial migration of neutrophils. Infect Immun 65(4):1217-1222
14. Pashenkov M, Teleshova N, Kouwenhoven M, Smirnova T, Jin YP, Kostulas V, Huang YM, Pinegin B, Boiko A, Link H (2002) Recruitment of dendritic cells to the cerebrospinal fluid in bacterial neuroinfections. J Neuroimmunol 122(1-2):106-116
15. Brown CR, Blaho VA, Loiacono CM (2003) Susceptibility to experimental Lyme arthritis correlates with KC and monocyte chemoattractant protein-1 production in joints and requires neutrophil recruitment via CXCR2. J Immunol 171(2):893-901
16. Kondrusik M, Swierzbinska R, Pancewicz S, Zajkowska J, Grygorczuk S, Hermanowska-Szpakowicz T (2004) Evaluation of proinflammatory cytokine (TNF-Alpha, IL-1beta, IL-6, IFNgamma) concentrations in serum and cerebrospinal fluid of patients with neuroborreliosis. Neurol Neurochir Pol 38(4):265-270
17. Grygorczuk S, Pancewicz S, Zajkowska J, Kondrusik M, Rwierzbinska R, Hermanowska-Szpakowicz T (2004) Concentrations of macrophage inflammatory proteins MIP-1alpha and MIP-1beta and interleukin 8 (il-8) in lyme borreliosis. Infection 32(6):350-355. doi:10.1007/s15010-004-3110-4
18. Grygorczuk S, Zajkowska J, Swierzbinska R, Pancewicz S, Kondrusik M, Hermanowska-Szpakowicz T (2005) Concentration of interferon-inducible T cell chemoattractant and monocyte chemotactic protein-1 in serum and cerebrospinal fluid of patients with Lyme borreliosis. Rocz Akad Med Bialymst 50:173-178
19. Benveniste EN (1992) Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol 263(1 Pt 1):C1-16
20. Merrill JE, Benveniste EN (1996) Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci 19(8):331-338
21. Raivich G, Bohatschek M, Kloss CU, Werner A, Jones LL, Kreutzberg GW (1999) Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function. Brain Res Brain Res Rev 30(1):77-105
22. Raivich G, Jones LL, Werner A, Bluthmann H, Doetschmann T, Kreutzberg GW (1999) Molecular signals for glial activation: pro-and anti-inflammatory cytokines in the injured brain. Acta Neurochir Suppl 73:21-30
23. Conductier G, Blondeau N, Guyon A, Nahon JL, Rovere C (2010) The role of monocyte chemoattractant protein MCP1/ CCL2 in neuroinflammatory diseases. J Neuroimmunol. doi:10. 1016/j.jneuroim.2010.05.010
24. Ramesh G, Borda JT, Dufour J, Kaushal D, Ramamoorthy R, Lackner AA, Philipp MT (2008) Interaction of the Lyme disease spirochete Borrelia burgdorferi with brain parenchyma elicits inflammatory mediators from glial cells as well as glial and neuronal apoptosis. Am J Pathol 173(5):1415-1427. doi:10.2353/ ajpath.2008.080483
25. Ramesh G, Borda JT, Gill A, Ribka EP, Morici LA, Mottram P, Martin DS, Jacobs MB, Didier PJ, Philipp MT (2009) Possible role of glial cells in the onset and progression of Lyme neuroborreliosis. J Neuroinflammation 6:23. doi:10.1186/1742-2094-6-23
26. Myers TA, Kaushal D, Philipp MT (2009) Microglia are mediators of Borrelia burgdorferi-induced apoptosis in SH-SY5Y neuronal cells. PLoS Pathog 5(11):e1000659. doi:10.1371/ journal.ppat.1000659
27. Ramesh G, Benge S, Pahar B, Philipp MT (2012) A possible role for inflammation in mediating apoptosis of oligodendrocytes as induced by the Lyme disease spirochete Borrelia burgdorferi. J Neuroinflammation 9:72. doi:10.1186/1742-2094-9-72
28. Baumann N, Pham-Dinh D (2001) Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81(2):871-927
29. Ebnet K, Brown KD, Siebenlist UK, Simon MM, Shaw S (1997) Borrelia burgdorferi activates nuclear factor-kappaB and is a potent inducer of chemokine and adhesion molecule gene expression in endothelial cells and fibroblasts. J Immunol 158(7):3285-3292
30. Schumann RR, Pfeil D, Freyer D, Buerger W, Lamping N, Kirschning CJ, Goebel UB, Weber JR (1998) Lipopolysaccharide and pneumococcal cell wall components activate the mitogen activated protein kinases (MAPK) erk-1, erk-2, and p38 in astrocytes. Glia 22(3):295-305
31. van der Bruggen T, Nijenhuis S, van Raaij E, Verhoef J, van Asbeck BS (1999) Lipopolysaccharide-induced tumor necrosis factor alpha production by human monocytes involves the raf-1/MEK1-MEK2/ERK1-ERK2 pathway. Infect Immun 67(8):3824-3829
32. Dong C, Davis RJ, Flavell RA (2002) MAP kinases in the immune response. Annu Rev Immunol 20:55-72. doi:10.1146/ annurev.immunol.20.091301.131133
33. Amaral JD, Castro RE, Steer CJ, Rodrigues CM (2009) p53 and the regulation of hepatocyte apoptosis: implications for disease pathogenesis. Trends Mol Med 15(11):531-541. doi:10.1016/j. molmed.2009.09.005
34. Vousden KH (2009) Functions of p53 in metabolism and invasion. Biochem Soc Trans 37(Pt 3):511-517. doi:10.1042/BST0370511
35. Vousden KH, Ryan KM (2009) p53 and metabolism. Nat Rev Cancer 9(10):691-700. doi:10.1038/nrc2715
36. Sadik CD, Hunfeld KP, Bachmann M, Kraiczy P, Eberhardt W, Brade V, Pfeilschifter J, Muhl H (2008) Systematic analysis highlights the key role of TLR2/NF-kappaB/MAP kinase signaling for IL-8 induction by macrophage-like THP-1 cells under influence of Borrelia burgdorferi lysates. Int J Biochem Cell Biol 40(11):2508-2521. doi:10.1016/j.biocel.2008.04.014
37. Anguita J, Barthold SW, Persinski R, Hedrick MN, Huy CA, Davis RJ, Flavell RA, Fikrig E (2002) Murine Lyme arthritis development mediated by p38 mitogen-Activated protein kinase activity. J Immunol 168(12):6352-6357
38. Izadi H, Motameni AT, Bates TC, Olivera ER, Villar-Suarez V, Joshi I, Garg R, Osborne BA, Davis RJ, Rincon M, Anguita J (2007) c-Jun N-terminal kinase 1 is required for Toll-like receptor 1 gene expression in macrophages. Infect Immun 75(10):5027-5034. doi:10.1128/IAI.00492-07
39. Olson CM, Hedrick MN, Izadi H, Bates TC, Olivera ER, Anguita J (2007) p38 mitogen-Activated protein kinase controls NF-kappaB transcriptional activation and tumor necrosis factor alpha production through RelA phosphorylation mediated by mitogenand stress-Activated protein kinase 1 in response to Borrelia burgdorferi antigens. Infect Immun 75(1):270-277. doi:10.1128/ IAI.01412-06
40. Hawley K, Navasa N, Olson CM Jr, Bates TC, Garg R, Hedrick MN, Conze D, Rincon M, Anguita J (2012) Macrophage p38 mitogen-Activated protein kinase activity regulates invariant natural killer T-cell responses during Borrelia burgdorferi infection. J Infect Dis 206(2):283-291. doi:10.1093/infdis/jis332
41. Takahashi P, Polson A, Reisman D (2011) Elevated transcription of the p53 gene in early S-phase leads to a rapid DNA-damage response during S-phase of the cell cycle. Apoptosis 16(9):950-958. doi:10.1007/s10495-011-0623-z
42. Persons DL, Yazlovitskaya EM, Pelling JC (2000) Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin. J Biol Chem 275(46):35778-35785. doi:10. 1074/jbc.M004267200
43. She QB, Chen N, Dong Z (2000) ERKs and p38 kinase phosphorylate p53 protein at serine 15 in response to UV radiation. J Biol Chem 275(27):20444-20449. doi:10.1074/jbc.M001020200
44. Yeh PY, Chuang SE, Yeh KH, Song YC, Chang LL, Cheng AL (2004) Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death. Oncogene 23(20):3580-3588. doi:10.1038/sj.onc. 1207426
45. Sears R, Nuckolls F, Haura E, Taya Y, Tamai K, Nevins JR (2000) Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev 14(19):2501-2514
46. Lavin MF, Gueven N (2006) The complexity of p53 stabilization and activation. Cell Death Differ 13(6):941-950. doi:10.1038/sj. cdd.4401925
47. Cagnol S, Chambard JC (2010)ERKand cell death: mechanisms of ERK-induced cell death-Apoptosis, autophagy and senescence. FEBS J 277(1):2-21. doi:10.1111/j.1742-4658.2009.07366.x
48. Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV, Gudkov AV (1999) A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285(5434):1733-1737
49. Strom E, Sathe S, Komarov PG, Chernova OB, Pavlovska I, Shyshynova I, Bosykh DA, Burdelya LG, Macklis RM, Skaliter R, Komarova EA, Gudkov AV (2006) Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation. Nat Chem Biol 2(9):474-479. doi:10.1038/ nchembio809
50. Speidel D (2010) Transcription-independent p53 apoptosis: an alternative route to death. Trends Cell Biol 20(1):14-24. doi:10. 1016/j.tcb.2009.10.002
51. Pelaia G, Vatrella A, Cuda G, Maselli R, Marsico SA (2003) Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases. Life Sci 72(14):1549-1561
52. Pelaia G, Cuda G, Vatrella A, Grembiale RD, De Sarro G, Maselli R, Costanzo FS, Avvedimento VE, Rotiroti D, Marsico SA (2001) Effects of glucocorticoids on activation of c-jun N-terminal, extracellular signal-regulated, and p38 MAP kinases in human pulmonary endothelial cells. Biochem Pharmacol 62(12):1719-1724
53. Ayroldi E, Cannarile L, Migliorati G, Nocentini G, Delfino DV, Riccardi C (2012) Mechanisms of the anti-inflammatory effects of glucocorticoids: genomic and nongenomic interference with MAPK signaling pathways. FASEB J 26(12):4805-4820. doi:10. 1096/fj.12-216382
54. Tang D, Wu D, Hirao A, Lahti JM, Liu L, Mazza B, Kidd VJ, Mak TW, Ingram AJ (2002) ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. J Biol Chem 277(15):12710-12717. doi:10.1074/jbc.M111598200
55. Xing Z, Cardona CJ, Anunciacion J, Adams S, Dao N (2010) Roles of the ERK MAPK in the regulation of proinflammatory and apoptotic responses in chicken macrophages infected with H9N2 avian influenza virus. J Gen Virol 91(Pt 2):343-351. doi:10.1099/vir.0.015578-0